Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL11739950 | 0.98 | GLA (0.71) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| Hydrochloric Acid SCHEMBL1127696 | 0.98 | GLA (0.78) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| SCHEMBL1194073 | 0.94 | GLA (0.71) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| Propionic Acid SCHEMBL5410798 | 0.93 | GLA (0.65) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| SCHEMBL30489760 | 0.92 | GLA (0.69) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| SCHEMBL1194005 | 0.92 | GLA (0.69) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| Hydrochloric Acid SCHEMBL1127992 | 0.92 | GLA (0.75) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| SCHEMBL9150763 | 0.92 | GLA (0.69) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| Hydrochloric Acid SCHEMBL30684598 | 0.90 | GLA (0.72) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 | |
| SCHEMBL10487039 | 0.89 | GLA (0.61) | GLASMN1; SMN2MAPK1CYP1A2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002358-A1 | Optically clear, taste-masked, shelf-stable nano-emulsions containing cannabinoids | CCT SCIENCES, LLC | 2024-01-04 | — | — | US | claimed |
| EP-2968145-A1 | MODIFIED DOCETAXEL LIPOSOME FORMULATIONS | Mallinckrodt LLC (US) | 2016-01-20 | — | — | EP | claimed |
| CN-105188675-A | Modified docetaxel liposome formulations | MALLINCKRODT LLC | 2015-12-23 | — | — | CN | claimed |
| EP-2724670-B1 | Detecting altered pH levels of rumens | KANKFELT PEKKA (FI) | 2015-06-17 | — | — | EP | claimed |
| WO-2014160392-A1 | MODIFIED DOCETAXEL LIPOSOME FORMULATIONS | MALLINCKRODT LLC (US) | 2014-10-02 | — | — | WO | claimed |
| EP-1637141-B1 | Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease | TROBIO AB (SE) | 2011-11-16 | — | — | EP | claimed |
| WO-2011131234-A1 | SENSOR APPARATUS ADAPTED TO BE INCORPORATED IN A GARMENT | WEARABLE INFORMATION TECHNOLOGIES, S.L. (WEARTECH) (ES) | 2011-10-27 | — | — | WO | claimed |
| US-20100113450-A1 | Agent for Preventing and Alleviating Wrinkles | SHISEIDO COMPANY LTD. (JP) | 2010-05-06 | — | — | US | claimed |
| EP-2123253-A1 | WRINKLING-PREVENTING AND -MODIFYING AGENT | Shiseido Company, Ltd. (JP) | 2009-11-25 | — | — | EP | claimed |
| US-20090136474-A1 | Stabilized Protease Composition | TROBIO AB (SE) | 2009-05-28 | — | — | US | claimed |
| WO-2007035143-A1 | STABILIZED PROTEASE COMPOSITION | TROBIO AB (SE) | 2007-03-29 | — | — | WO | claimed |
| EP-1637141-A1 | Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease | Trobio AB (SE) | 2006-03-22 | — | — | EP | claimed |
| EP-0765160-B1 | DEXANABINOL DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | UNIV RAMOT (IL) | 2003-04-16 | — | — | EP | claimed |
| US-6096740-A | BLOCK N-METHYL-ASPARTATE | RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH AND INDUSTRIAL DEVELOPMENT LTD. (IL) | 2000-08-01 | — | — | US | claimed |
| EP-0553174-B1 | ARYLPYRIDAZINONES | BYK GULDEN LOMBERG CHEM FAB (DE) | 1998-07-08 | — | — | EP | claimed |
| EP-0765160-A4 | — | — | 1997-04-09 | — | — | EP | claimed |
| EP-0765160-A1 | DEXANABINOL DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | RAMOT UNIVERSITY, AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) | 1997-04-02 | — | — | EP | claimed |
| WO-1995020958-A1 | DEXANABINOL DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH AND INDUSTRIAL DEVELOPMENT LTD. (IL) | 1995-08-10 | — | — | WO | claimed |
| EP-0125636-B1 | PYRIDAZINONES, THEIR PREPARATION AND USE, MEDICINES CONTAINING THESE PYRIDAZINONES | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1987-04-01 | — | — | EP | claimed |
| WO-1984004521-A1 | PYRIDAZINONES, THEIR PREPARATION AND USE, AND MEDICAMENTS CONTAINING PYRIDAZINONES | BYK GULDEN LOMBERG CHEM FAB (DE) | 1984-11-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090136474-A1 | Stabilized Protease Composition | SERPINE1, SERPINB1, CTRL | GLA 221/4885SMN1; SMN2 655/4885MAPK1 3866/4885 |
| US-20100113450-A1 | Agent for Preventing and Alleviating Wrinkles | GABRB1, GABRB2, GABBR1 | GLA 28/4885SMN1; SMN2 1147/4885MAPK1 2400/4885 |
| US-20240002358-A1 | Optically clear, taste-masked, shelf-stable nano-emulsions containing cannabinoids | CNR2, CNR1, TAS2R10 | GLA 1996/4885SMN1; SMN2 1534/4885MAPK1 4269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.